27% growth in prescriptions dispensed over prior quarter; 147% growth over comparable quarter in 2022. 5 consecutive quarters of double-digit growth. Click here to learn more ›

Distress Reduction in Female Sexual Dysfunctions: A Dose‐Ranging Study of Subcutaneous Bremelanotide

Leave a Reply

Scroll to Top